A new type of immunotherapy that targets macrophages has undergone preliminary testing on mice and shows promise for the future treatment of ovarian cancer; the study is headed by Anders Etzerodt from Aarhus University, Denmark AARHUS UNIVERSITY Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease...